LLY ▲ +0.4% - Eli Lilly and Company $LLY - Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions Eli Lilly rose 0.4% after announcing its completion of the AtaiBeckley acquisition, which expands the company's pipeline for treatment-resistant depression and other mental health disorders. The deal brings novel therapeutic approaches into Lilly's portfolio at a time when demand for advanced mental health treatments continues to grow. 11-SEP-2026 09:03 AM ET